Iatrogenic Tricuspid Regurgitation Associated With Pacemakers

Duncan, Rory R.; Sharma, Rakesh; Vazir, Ali; Rosendahl, Ulrich; Duncan, Alison

doi:10.1016/j.jaccas.2023.101772

Cited by 2 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Multiple reports have described interferences between CIED leads or LCPM and the TV apparatus ( Table 1 and Figure 1 ), pacing itself resulting in TR, or more rarely provoking tricuspid stenosis. 24 While in many patients, CIED and TR coexist (CIED-associated TR), a causal relationship should be assumed when TR of any grade appears or pre-existing TR worsens following right ventricular (RV) lead insertion. 25 Further, demonstration of well-delineated lead–leaflet interaction also suffices to diagnose CIED-related TR ( Graphical Abstract ).…”

Section: Definition and Terminologymentioning

confidence: 99%

Tricuspid valve disease and cardiac implantable electronic devices

Andreas,

Burri,

Praz

et al. 2023

European Heart Journal

View full text Add to dashboard Cite

The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs. This multidisciplinary review article developed with electrophysiologists, interventional cardiologists, imaging specialists, and cardiac surgeons aims to give an overview of the mechanisms of disease, diagnostics, and proposes treatment algorithms of patients suffering from TR associated with CIED lead(s) or leadless pacemakers.

show abstract

Section: Definition and Terminologymentioning

confidence: 99%

Tricuspid valve disease and cardiac implantable electronic devices

Andreas,

Burri,

Praz

et al. 2023

European Heart Journal

View full text Add to dashboard Cite

show abstract

Bloqueo auriculoventricular de tercer grado: caso clínico

Loaiza,

Morgado,

Yambay

2024

rgn

View full text Add to dashboard Cite

El bloqueo auriculoventricular (BAV) es un trastorno eléctrico cardíaco caracterizado por una conducción alterada de las aurículas a los ventrículos. Este artículo tiene por objetivo reportar el caso clínico de una paciente con BAV de tercer grado sintomático y realizar una revisión de la literatura de los factores de riesgo, diagnóstico y tratamiento. La metodología aplicada fue un estudio observacional, descriptivo, retrospectivo. Se realizó una búsqueda bibliográfica en: Google Académico, PubMed, Science Direct y en Scielo de estudios de los últimos cinco años en español e inglés. Se seleccionaron 36 publicaciones. Los factores de riesgo más frecuentes fueron: hipertensión, edad avanzada, sexo masculino, bradicardia marcada, etc. El diagnóstico se basa en el electrocardiograma para determinar el BAV, el ecocardiograma transtorácico. El tratamiento requiere de la implantación de un marcapasos (MP) definitivo, concluyendo que es importante monitorizar periódicamente el funcionamiento del MP implantado para prevenir complicaciones.

show abstract

Iatrogenic Tricuspid Regurgitation Associated With Pacemakers

Cited by 2 publications

References 8 publications

Tricuspid valve disease and cardiac implantable electronic devices

Tricuspid valve disease and cardiac implantable electronic devices

Bloqueo auriculoventricular de tercer grado: caso clínico

Contact Info

Product

Resources

About